Results 61 to 70 of about 1,636,890 (348)

Insights into PI3K/AKT signaling in B cell development and chronic lymphocytic leukemia

open access: yesFEBS Letters, EarlyView.
This Review explores how the phosphoinositide 3‐kinase and protein kinase B pathway shapes B cell development and drives chronic lymphocytic leukemia, a common blood cancer. It examines how signaling levels affect disease progression, addresses treatment challenges, and introduces novel experimental strategies to improve therapies and patient outcomes.
Maike Buchner
wiley   +1 more source

Colorectal Cancer in Octogenarians: Results of Treatment, a Descriptive Clinical Study [PDF]

open access: yesIranian Journal of Colorectal Research, 2016
Background: Colorectal cancers (CRCs) often occur in octogenarians. However, data on treatment and survival are sparse.Objectives: Octogenarians were studied in order to gain data on treatment, outcomes, and survival related to CRC.Patients and Methods ...
Elmer van Eeghen   +2 more
doaj  

The power of microRNA regulation—insights into immunity and metabolism

open access: yesFEBS Letters, EarlyView.
MicroRNAs are emerging as crucial regulators at the intersection of metabolism and immunity. This review examines how miRNAs coordinate glucose and lipid metabolism while simultaneously modulating T‐cell development and immune responses. Moreover, it highlights how cutting‐edge artificial intelligence applications can identify miRNA biomarkers ...
Stefania Oliveto   +2 more
wiley   +1 more source

Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial–mesenchymal transition and tumor‐infiltrating lymphocytes

open access: yesMolecular Oncology, EarlyView.
Epithelial–mesenchymal transition (EMT) and tumor‐infiltrating lymphocytes (TILs) are associated with early breast cancer response to neoadjuvant chemotherapy (NAC). This study evaluated EMT and TIL shifts, with immunofluorescence and RNA sequencing, at diagnosis and in residual tumors as potential biomarkers associated with treatment response.
Françoise Derouane   +16 more
wiley   +1 more source

Risk and Secondary Prevention of Stroke Recurrence

open access: yesStroke, 2020
Supplemental Digital Content is available in the text. Background and Purpose: With recent advances in secondary prevention management, stroke recurrence rates may have changed substantially.
C. Flach   +4 more
semanticscholar   +1 more source

Recurrently Controlled Recurrent Networks

open access: yes, 2018
Recurrent neural networks (RNNs) such as long short-term memory and gated recurrent units are pivotal building blocks across a broad spectrum of sequence modeling problems. This paper proposes a recurrently controlled recurrent network (RCRN) for expressive and powerful sequence encoding.
Tay, Yi, Tuan, Luu Anh, Hui, Siu Cheung
openaire   +2 more sources

Recurrence without uniform recurrence [PDF]

open access: yesErgodic Theory and Dynamical Systems, 1987
AbstractWe construct a minimal homeomorphism of a compact space such that a sequence of its iterates converges pointwise to the identity but no sequence of its iterates converges uniformly.
openaire   +2 more sources

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

open access: yesMolecular Oncology, EarlyView.
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park   +6 more
wiley   +1 more source

Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.

open access: yesAnnals of Surgery, 2019
OBJECTIVES To establish an evidence-based cutoff to differentiate between early and late recurrence and to compare clinicopathologic risk factors between the two groups.
V. Groot   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy